On March 9, 2018 Crescendo Biologics Limited (Crescendo), the drug developer of novel,
targeted T-cell engaging therapeutics, reported that Peter Pack, CEO and Brian McGuiness, Head of
New Product and Business Development, will be in Amsterdam from 12-14 March for the 12th Annual
BIO-Europe Spring 2018 conference (Press release, Crescendo Biologics, MAR 9, 2018, View Source [SID1234525090]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

With a focus on European innovation and global collaboration, BIO-Europe Spring is a partnering
conference for biotech, pharma and finance professionals in the most innovative biopharma clusters in
Europe.

To arrange a meeting with the team, please send a request through the conference partnering system.